Beam Therapeutics Inc. (BEAM)
NASDAQ: BEAM · Real-Time Price · USD
25.79
-1.40 (-5.15%)
At close: Oct 16, 2025, 4:00 PM EDT
24.64
-1.15 (-4.46%)
Pre-market: Oct 17, 2025, 6:25 AM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Genetic Medicines
63.52M
Log In
Log In
Log In
Log In
Upgrade
Genetic Medicines Growth
-83.18%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
63.52M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-83.18%
Log In
Log In
Log In
Log In
Upgrade